Saint Lucia vs Saint Vincent and the Grenadines: The number of people with susceptibility test result for rifampicin
Saint Lucia
2
in 2021
Saint Vincent and the Grenadines
0
in 2021
Saint Lucia rank
143rd
Saint Vincent and the Grenadines rank
146th
The number of people with susceptibility test result for rifampicin over time
- Saint Lucia
- Saint Vincent and the Grenadines
How they compare
Saint Lucia currently reports 2 against 0 in Saint Vincent and the Grenadines, a difference of 2.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Saint Lucia ahead.
Saint Lucia ranks 143rd and Saint Vincent and the Grenadines ranks 146th of 155 countries.
Across the 2 decades both report, Saint Lucia averaged higher in 1 and Saint Vincent and the Grenadines in 1.
Head to head by decade
| Decade | Saint Lucia | Saint Vincent and the Grenadines | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 5 | 3.33 | 1.67 | Saint Lucia |
| 2020s | 2.5 | 6.5 | 4 | Saint Vincent and the Grenadines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Saint Lucia or Saint Vincent and the Grenadines?
- Saint Lucia, at 2 against 0 in Saint Vincent and the Grenadines as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Saint Lucia and Saint Vincent and the Grenadines?
- 2, with Saint Lucia ahead.
- How many years of comparable data are there for Saint Lucia and Saint Vincent and the Grenadines?
- 5 years are reported by both, from 2017 to 2021.
- How do Saint Lucia and Saint Vincent and the Grenadines rank globally for the number of people with susceptibility test result for rifampicin?
- Saint Lucia ranks 143rd and Saint Vincent and the Grenadines ranks 146th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.